Analysis of mtDNA sequence variants in colorectal adenomatous polyps

Diagnostic Pathology

Volumn 5, Issue 1, 2010, Pages

  Mehrabi, Sharifeh ^a   Akwe, Joyce A ^a   Adams Jr, Gregory ^a   Grizzle, William ^b   Yao, Xuebiao ^a   Aikhionbare, Felix O ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADENOMATOUS POLYP; AGED; ARTICLE; BIOPSY; CLASSIFICATION; COLON POLYP; COLORECTAL TUMOR; DISEASE COURSE; GENETIC DATABASE; GENETIC VARIABILITY; GENETICS; HUMAN; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS;

ADENOMATOUS POLYPS; AGED; BIOPSY; COLONIC POLYPS; COLORECTAL NEOPLASMS; DATABASES, GENETIC; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; GENETIC VARIATION; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 77957358841     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-5-66     Document Type: Article

References (19)

1. O'Brien M, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Diaz B, Dickersin GR, Ewing S, Geller S, Kasimian D, Komorowski R, Szporn A. The National Polyp Study Workgroup. The National Polyp Study. Patient and Polyp Characteristics Associated With High-Grade Dysplasia in Colorectal Adenomas. Gastroenterology 1990, 98:371-379.
2. Sheikh RA, Yasmeen S, Prindiville T, Rnebnei BH. Biological markers and colorectal cancer. JK-Practitioner 2002, 9(4):215-218.
3. Fearson ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:769-67. 10.1016/0092-8674(90)90187-J, 2188736.
4. Vogelstein B, Fearon ER, Hamilton SR, Kem SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetics alterations during colo-rectal tumors development. N Eng J Med 1988, 319:525-532.
5. Fearson ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987, 238:193-197. 10.1126/science.2889267, 2889267.
6. Aikhionbare FO, Mehrabi S, Thompson W, Yao X, Grizzle X, Partridge E. mtDNA sequence variants in subtypes of epithelial ovarian cancer stages in relation to ethnic and age difference. Diagnostic Pathology 2008, 3:32. 10.1186/1746-1596-3-32, 2494992, 18662401.
7. Aikhionbare FO, Khan M, Carey D, Okoli J, Go R. Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression?. Molecular Cancer 2004, 526214, 15482594.
8. Theodoratou E, Din FV, Farrington SM, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG, Campbell H, Tenesa A. Association between common mtDNA variants and all-cause or colorectal cancer mortality. Carcinogenesis 2010, 31(2):296-301. 10.1093/carcin/bgp237, 19945968.
9. Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997, 94:514-519. 10.1073/pnas.94.2.514, 19544, 9012815.
10. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi JI. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastatsis. Science 2008, 320:661-664. 10.1126/science.1156906, 18388260.
11. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995, 358:1-3. 10.1016/0014-5793(94)01368-B, 7821417.
12. Aikhionbare FO, Mehrabi S, Kumaresn K, Zavareh M, Olatinwo M, Odunsi K, Partridge E. Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J Carcinogenesis 2007, 6:1.
13. Yoned MA, Chomyn A, Martinuzzi A, HuRKot O, Attardi G. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proc Natl Acad Sci USA 1992, 89:11164-11168. 10.1073/pnas.89.23.11164, 50510, 1454794.
14. Nishikawa M, Oshitani N, Matsumoto T, Nishigami T, Arakawa T, Inoue M. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. British Journal of cancer 2005, 93:331-337. 10.1038/sj.bjc.6602664, 2361569, 15956973.
15. Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G, Oda H, Ohta S. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 2005, 65:1655-63. 10.1158/0008-5472.CAN-04-2012, 15753359.
16. Kirches E. Mitochondrial and nuclear genes of mitochondrial components in cancer. Curr Genomics 2009, 10(4):281-93. 10.2174/138920209788488517, 2709939, 19949549.
17. Klein RD, Jin L, Rumilla K, Young WF, Lloyd RV. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas. Diagn Mol Pathol 2008, 17(2):94-100. 10.1097/PDM.0b013e318150d67c, 18382370.
18. Loy TS, Kaplan PA. Villous Adenocarcinoma of the Colon and Rectum A Clinicopathologic Study of 36 Cases. Am J Surg Pathol 2004, 28:1460-1465. 10.1097/01.pas.0000141394.64707.02, 15489649.
19. Palazzo JP, Edmonston TB, Chaille-Arnold LM, Burkholder S. Invasive papillary adenocarcinoma of colon. Hum Pathol 2002, 33:372-375. 10.1053/hupa.2002.32228, 11979380.